ALDEN BUNYAN: Open Payments
NPI 1265175574 · BEVERLY HILLS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,578 in 162 payments from 21 companies in 2025. Trend: 2023 $2,104 · 2024 $2,994 · 2025 $3,578
Food & beverage: $3,573Education: $6
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 39 | $853 |
| Amgen Inc. | 23 | $492 |
| Lilly USA, LLC | 11 | $341 |
| UCB, Inc. | 19 | $337 |
| GlaxoSmithKline, LLC. | 12 | $232 |
| Novartis Pharmaceuticals Corporation | 7 | $208 |
| PFIZER INC. | 9 | $185 |
| Radius Health, Inc. | 7 | $177 |
| Janssen Biotech, Inc. | 11 | $171 |
| Alexion Pharmaceuticals, Inc. | 5 | $136 |
Products named: RINVOQ, TALTZ, Bimzelx, BENLYSTA, SKYRIZI, Tymlos, TREMFYA, XELJANZ.
Industry payments across CA — which companies pay providers there.
